rewan khalil

Dr. rewan khalil


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
MAMohamed M. Ammar
Mohamed M. Ammar
RARania Ali
Rania Ali
NENaira Ali Abd Elaziz
Naira Ali Abd Elaziz
HHHeba Habib
Heba Habib
FAFatima M. Abbas
Fatima M. Abbas
RKrewan khalil
rewan khalil
Nanotechnology has revolutionized oncology by offering innovative solutions to overcome the limitations of conventional cancer therapies. This review explores the transformative potential of nanotechnology in cancer diagnosis, treatment, and drug delivery, emphasizing the development of sustainable nanocomposites derived from natural sources such as plants and microbes. These eco-friendly nanocomposites enhance therapeutic efficacy, minimize environmental impact, and align with green chemistry principles. Nanoparticles (NPs) enable targeted drug delivery through mechanisms like the enhanced permeability and retention (EPR) effect and active targeting, reducing systemic toxicity and improving treatment outcomes. They also facilitate gene therapy, photothermal and photodynamic therapies, and immune modulation, including the development of cancer vaccines and theranostic platforms. Despite their promise, challenges such as nanoparticle toxicity, immune clearance, and long-term biocompatibility persist. Advances in biodegradable and stimuli-responsive NPs aim to address these issues, ensuring safer and more effective applications. The integration of nanotechnology with personalized medicine and combination therapies holds significant potential for improving cancer treatment efficacy and patient outcomes. However, further research is needed to optimize nanoparticle design, enhance tumor targeting, and ensure clinical translation. This review highlights the critical role of nanotechnology in advancing cancer therapy, underscoring its potential to redefine treatment paradigms while addressing current limitations and future prospects.

27 February 2024 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
RKrewan khalil
rewan khalil
YTYasmine Hasanine Tartor
Yasmine Hasanine Tartor
ABAhmed B. Barakat
Ahmed B. Barakat
GEGamal El-Didamony
Gamal El-Didamony
MGMarwa M. Gado
Marwa M. Gado
Hanaa Awad ElsamadonyHanaa Awad Elsamadony
Hanaa Awad Elsamadony
Background: Newcastle Disease Virus (NDV) causes severe economic losses in the poultry industry worldwide. Hence, this study aimed to discover a novel bioactive antiviral agent for controlling NDV. Streptomyces misakiensis was isolated from Egyptian soil and its secondary metabolites were identified using infrared spectroscopy (IR), gas chromatography–mass spectrometry (GC–MS), and nuclear magnetic resonance (NMR) spectroscopy. The inhibitory activity of bioactive metabolite against NDV were examined. Three experimental groups of 10-day-old specific pathogen-free embryonated chicken eggs (SPF-ECEs), including the bioactive metabolite control group, NDV control positive group, and α-sitosterol and NDV mixture-treated group were inoculated. Results: α-sitosterol (Ethyl-6-methylheptan-2-yl]-10,13-dimethyl-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol), a secondary metabolite of S. misakiensis, completely inhibited hemagglutination (HA) activity of the NDV strain. The HA activity of the NDV strain was 8 log2 and 9 log2 for 0.5 and 0.75% RBCs, respectively. The NDV HA activity for the two concentrations of RBCs was significantly (P < 0.0001) inhibited after α-sitosterol treatment. There was a significant (P < 0.0001) decrease in the log 2 of HA activity, with values of − 0.500 (75%, chicken RBCs) before inoculation in SPF-ECEs and − 1.161 (50%, RBCs) and − 1.403 (75%, RBCs) following SPF-ECE inoculation. Compared to ECEs inoculated with NDV alone, the α-sitosterol-treated group showed improvement in histological lesion ratings for chorioallantoic membranes (CAM) and hepatic tissues. The CAM of the α-sitosterol- inoculated SPF-ECEs was preserved. The epithelial and stromal layers were noticeably thicker with extensive hemorrhages, clogged vasculatures, and certain inflammatory cells in the stroma layer in the NDV group. However, mild edema and inflammatory cell infiltration were observed in the CAM of the treated group. ECEs inoculated with α-sitosterol alone showed normal histology of the hepatic acini, central veins, and portal triads. Severe degenerative alterations, including steatosis, clogged sinusoids, and central veins, were observed in ECEs inoculated with NDV. Mild hepatic degenerative alterations, with perivascular round cell infiltration, were observed in the treated group. Conclusion: To the best of our knowledge, this is the first study to highlight that the potentially bioactive secondary metabolite, α-sitosterol, belonging to the terpene family, has the potential to be a biological weapon against virulent NDV. It could be used for the development of innovative antiviral drugs to control NDV after further clinical investigation.

12 January 2026 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
RKrewan khalil
rewan khalil
SASaeedah M. Almutairi
Saeedah M. Almutairi
MYMohamed T. Yassin
Mohamed T. Yassin
MAMohamed R. AbdelGawwad
Mohamed R. AbdelGawwad
RARania Ali
Rania Ali
SASheeren Abdelaziz
Sheeren Abdelaziz
Fungal infection, particularly that caused by Candida albicans, pose emerging challenges in aquaculture, leading to significant economic and health losses

26 July 2022 in Research Square
Verified
Preprint
Open access
PDF file
RKrewan khalil
rewan khalil
ABAhmed B. Barakat
Ahmed B. Barakat
GEGamal El-Didamony
Gamal El-Didamony
YTYasmine H. Tartor
Yasmine H. Tartor
MGMarwa M. Gado
Marwa M. Gado
Hanaa Awad ElsamadonyHanaa Awad Elsamadony
Hanaa Awad Elsamadony
Background The Newcastle Disease Virus (NDV) is present throughout the world, and outbreaks in Egypt caused serious economic losses in the poultry industry. Actinobacteria are a phylum of bacteria known for their potential in producing structurally diversified natural products which promising natural compounds used to combat viruses are presented and evaluated. Streptomyces Misakimycin isolated from Egyptian soil, and evaluated for their efficacy in controlling NDV. On the basis of the biochemical characteristics S. Misakimycin metabolites, identified by infrared (IR) and nuclear magnetic resonance (NMR) spectroscopy. Results In this investigation, NDV was found to have been isolated in February from a chicken farm in the Dakahlia Governorate of Egypt by the Animal Health Research Institute in Dokki, Giza. Diethylpthalate (DEP), a secondary metabolite of S. misakimycin, completely inhibited the hemagglutination (HI) activity of the NDV strain (MN635617) at log107 infectivity titers (EID50/mL). With 0.5 percent and 0.75 percent of chicken RBCs, the HA of the NDV strain was 2 log2 and 5 log2, respectively. In the treated group that received DEP and NDV inoculations, chorioallantoic-membranes (CAM) structures were preserved along with dilated capillary networks. Histological changes in SPF-ECE liver were examined after inoculation in ova to further characterize the DEP effect. Diethylpthalate and NDV mixture inoculated group showed preserved cytoarchitecture of hepatocytes with the presence of perivascular foci of lymphocytes. The group that was inoculated with telomycin alone showed normal histology of hepatic acini, central veins, and portal triads. Conclusion A potentially bioactive substance called diethylpthalate has the potential to be a biological weapon against a fatal chicken NDV that quickly increase cost losses for farmers.

19 May 2026 in Fish Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
RKrewan khalil
rewan khalil
SASaeedah M. Almutairi
Saeedah M. Almutairi
MAMohamed R. AbdelGawwad
Mohamed R. AbdelGawwad
KAKasim Sakran Abass
Kasim Sakran Abass
SASheeren Abdelaziz
Sheeren Abdelaziz
MYMohamed Taha Yassin
Mohamed Taha Yassin